Equity MRK
Monday, February 18, 2019   
Asian Paints  1379.75    (-1.11%)
 
Axis Bank  692.60    (0.88%)
 
Bajaj Auto  2794.15    (-0.88%)
 
Bajaj Fin.  2545.95    (-0.45%)
 
Bharti Airtel  302.50    (-0.61%)
 
Coal India  215.10    (-1.74%)
 
H D F C  1874.55    (-0.03%)
 
HCL Technologi...  1047.25    (-1.00%)
 
HDFC Bank  2089.95    (-0.53%)
 
Hero Motocorp  2683.45    (-0.70%)
 
Hind. Unilever  1752.30    (-1.17%)
 
ICICI Bank  338.55    (-1.01%)
 
IndusInd Bank  1516.95    (0.47%)
 
Infosys  740.10    (-0.22%)
 
ITC  274.15    (-1.95%)
 
Kotak Mah. Ban...  1278.15    (-0.44%)
 
Larsen & Toubr...  1240.25    (-0.24%)
 
M & M  623.65    (-0.66%)
 
Maruti Suzuki  6844.40    (-1.17%)
 
NTPC  136.85    (0.48%)
 
O N G C  137.10    (1.48%)
 
Power Grid Cor...  180.65    (-0.47%)
 
Reliance Inds.  1219.75    (-1.91%)
 
St Bk of India  259.75    (-1.22%)
 
Sun Pharma.Ind...  415.10    (-1.94%)
 
Tata Motors  163.00    (1.18%)
 
Tata Motors-DV...  84.30    (0.60%)
 
Tata Steel  465.75    (-0.36%)
 
TCS  1971.75    (-2.91%)
 
Vedanta  148.00    (0.37%)
 
Yes Bank  213.15    (-2.54%)
 
Market Menu
plusminDaily Market Tracker
plusminNews
Corporate Information
Corporate Actions
Other Markets
Close
You are here : Equity | News | Corporate News
Cadila Healthcare's JV facility of Zydus Hopsira Oncology receives EIR from USFDA
(13:08, 12 Jul 2018)
Cadila Healthcare announced that the manufacturing facility of Zydus Hopsira Oncology, a 50:50 joint venture company between Zydus Cadila and Hospira Inc., USA (now part of Pfizer Group) at Ahmedabad has received an Establishment Inspection Report (EIR) from the USFDA which concluded that the inspection is closed and states that theinspection classification of this facility is 'Voluntary Action Indicated' (VAI). The manufacturing plant had completed the USFDA audit from 5 to 12 April, 2018.

Powered by Capital Market - Live News